Farydak (panobinostat)
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for Farydak (panobinostat), covering 2015-03-06 to 2017-07-02. Get the full timeline:
Most recent: Clinical Trial Update: Treatment of Resistant Metastatic Melanoma Using Decitabine, Temozolomide and Panobinostat [Phase 1, Phase 2]